データなし
データなし
Catalyst Watch: Labor Pains for Amazon & Starbucks, Nasdaq Call-up for MicroStrategy and Pony AI Ratings
Neumora Therapeutics Price Target Maintained With a $30.00/Share by HC Wainwright & Co.
Watching Neumora Therapeutics; Shares See Volume To The Upside, Traders Circulate Unconfirmed Analyst Comments Saying "We Remain Buyers Into NMRA's MDD Data, Citing JNJ's Early Completion Of Phase III Aticaprant Study Efficacy And Safety Profile,...
10 Health Care Stocks With Whale Alerts In Today's Session
Neumora Therapeutics, Inc. (NMRA): This Small-Cap Stock Is Ready To Explode
This Biotech's Stock Could Double If Its Treatment for Major Depressive Disorder Succeeds, Says Mizuho
このコンテンツを閲覧するにはログインが必要です。